Search Results - "Hong, Seokhyun"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Abstract 1135: Antitumor activity of novel reversible LSD1 inhibitors in preclinical models of AML and SCLC

    Abstract 1135: Antitumor activity of novel reversible LSD1 inhibitors in preclinical models of AML and SCLC by Byun, Joo-Yun, Lee, Won Jong, Kim, Won jung, Kim, Minjeong, Bae, Inhwan, Hong, Seokhyun, Kim, Yu-Yon, Park, Hyunjin, Kim, Eunyoung, Kim, Young Hoon, Ahn, Young Gil, Suh, Kwee Hyun

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Lysine-specific demethylase 1 (LSD1) has become a biologically important and validated epigenetic target for cancer therapy since its identification in 2004…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Abstract 3833: Antitumor activity of novel reversible LSD1 inhibitor in preclinical models of AML and SCLC

    Abstract 3833: Antitumor activity of novel reversible LSD1 inhibitor in preclinical models of AML and SCLC by Bae, InHwan, Kim, WonJeoun, Kim, JiSook, Song, JiYoung, Nam, JungSoo, Lee, Moonsub, Byun, Jooyun, Kim, Hyeongki, Song, TaeHun, Hong, Seokhyun, Lee, KyuHang, Ahn, YoungGil, Kim, YoungHoon, Suh, Kwee Hyun

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Introduction: Global changes in the epigenetic landscape are known as the hallmark in cancer and the histone demethylase Lysine-specific demethylase 1 (LSD1)…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Abstract 3335: A novel and potent IRE1α RNase inhibitor, HM100168 as a promising therapeutic strategy in solid cancers

    Abstract 3335: A novel and potent IRE1α RNase inhibitor, HM100168 as a promising therapeutic strategy in solid cancers by Kim, Jisook, Jung, Seung Hyun, Kim, Minjeong, Park, Wongi, Byun, Jooyun, Park, Soonki, Lee, Miyoung, Kim, Yu-Yon, Park, Junghwa, Hong, Seokhyun, Kim, Minhwa, Ahn, Young Gil

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Protein folding homeostasis in the endoplasmic reticulum (ER) is regulated by a signaling network called the unfolded protein response (UPR)…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Abstract 4871: Antitumor activity of novel reversible LSD1 inhibitor, HM97211 in preclinical models of SCLC

    Abstract 4871: Antitumor activity of novel reversible LSD1 inhibitor, HM97211 in preclinical models of SCLC by Bae, InHwan, Kim, JiSook, Park, ChangHee, Kim, Hyeongki, Gwangmog, Namgoong, Byun, Joo-Yun, Hong, Seokhyun, Song, Teahun, Lee, JaeHo, Lee, Kyuhang, Ko, Myoungsil, Kim, Cheolkyung, Lee, YoungMi, Lee, Ho Jeong, Kim, YoungHoon, Ahn, YoungGil, Suh, KweeHyun, Kim, Sun-Jin

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Introduction: Global changes in the epigenetic landscape are known as the hallmark in cancer and the histone demethylase Lysine-specific demethylase 1 (LSD1)…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: